- IBDEI0BF ; ; 01-AUG-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,326,0)
- ;;=PMH / OTHER^22^37
- ;;^UTILITY(U,$J,358.4,327,0)
- ;;=RETINA - VEGF INJECT DX CODES^16^37
- ;;^UTILITY(U,$J,358.4,328,0)
- ;;=RETINA - DIABETIC RETINOPATHY^13^37
- ;;^UTILITY(U,$J,358.4,329,0)
- ;;=COVID-19 & RELATED^24^37
- ;;^UTILITY(U,$J,358.4,330,0)
- ;;=NEW PATIENT^3^38
- ;;^UTILITY(U,$J,358.4,331,0)
- ;;=ESTABLISHED PATIENT^2^38
- ;;^UTILITY(U,$J,358.4,332,0)
- ;;=CONSULTS - OUTPT^4^38
- ;;^UTILITY(U,$J,358.4,333,0)
- ;;=EYE CODES^1^38
- ;;^UTILITY(U,$J,358.4,334,0)
- ;;=CONSULTS - INPT^5^38
- ;;^UTILITY(U,$J,358.4,335,0)
- ;;=HOSPITAL CARE - INITIAL^6^38
- ;;^UTILITY(U,$J,358.4,336,0)
- ;;=HOSPITAL CARE - SUBSEQUENT^7^38
- ;;^UTILITY(U,$J,358.4,337,0)
- ;;=HOSPITAL CARE - DISCHARGE^8^38
- ;;^UTILITY(U,$J,358.4,338,0)
- ;;=OBSERVATION CARE - INITIAL^9^38
- ;;^UTILITY(U,$J,358.4,339,0)
- ;;=OBSERVATION CARE - SUBSEQUENT^10^38
- ;;^UTILITY(U,$J,358.4,340,0)
- ;;=OBSERVATION CARE - DISCHARGE^11^38
- ;;^UTILITY(U,$J,358.4,341,0)
- ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^38
- ;;^UTILITY(U,$J,358.4,342,0)
- ;;=EEF Version 2022 July^13^38
- ;;^UTILITY(U,$J,358.4,343,0)
- ;;=PROC - LID / LACRIMAL^7^39
- ;;^UTILITY(U,$J,358.4,344,0)
- ;;=PROC - LASER / CRYO^10^39
- ;;^UTILITY(U,$J,358.4,345,0)
- ;;=PROC - CORNEA / CONJ^6^39
- ;;^UTILITY(U,$J,358.4,346,0)
- ;;=MEDICATIONS^12^39
- ;;^UTILITY(U,$J,358.4,347,0)
- ;;=PROC - INJECTIONS / ALL^9^39
- ;;^UTILITY(U,$J,358.4,348,0)
- ;;=IMAGE / PHOTOS^2^39
- ;;^UTILITY(U,$J,358.4,349,0)
- ;;=REFRACT / GLASSES / CL^1^39
- ;;^UTILITY(U,$J,358.4,350,0)
- ;;=TEST - CATARACT / CORNEA^4^39
- ;;^UTILITY(U,$J,358.4,351,0)
- ;;=TEST - GLAUCOMA^3^39
- ;;^UTILITY(U,$J,358.4,352,0)
- ;;=TEST - OTHER^5^39
- ;;^UTILITY(U,$J,358.4,353,0)
- ;;=EDUCATION / COUNSELING^13^39
- ;;^UTILITY(U,$J,358.4,354,0)
- ;;=EYE SURGERY CODES^11^39
- ;;^UTILITY(U,$J,358.4,355,0)
- ;;=PROC - INJECTIONS / VEGF^8^39
- ;;^UTILITY(U,$J,358.4,356,0)
- ;;=TEST - ERG / VEP^14^39
- ;;^UTILITY(U,$J,358.4,357,0)
- ;;=LOW VISION / BLINDNESS^21^40
- ;;^UTILITY(U,$J,358.4,358,0)
- ;;=RETINA - VASCULAR^12^40
- ;;^UTILITY(U,$J,358.4,359,0)
- ;;=EYELIDS / LASHES^2^40
- ;;^UTILITY(U,$J,358.4,360,0)
- ;;=NEURO / STRABISMUS^18^40
- ;;^UTILITY(U,$J,358.4,361,0)
- ;;=ORBIT - PLASTICS^20^40
- ;;^UTILITY(U,$J,358.4,362,0)
- ;;=VITREOUS^17^40
- ;;^UTILITY(U,$J,358.4,363,0)
- ;;=ORBIT - TRAUMA^19^40
- ;;^UTILITY(U,$J,358.4,364,0)
- ;;=LACRIMAL / NLD / NEOPLASMS^3^40
- ;;^UTILITY(U,$J,358.4,365,0)
- ;;=MOST FREQUENT^1^40
- ;;^UTILITY(U,$J,358.4,366,0)
- ;;=CONJUNCTIVA / SCLERA^4^40
- ;;^UTILITY(U,$J,358.4,367,0)
- ;;=CORNEA / ULCER^5^40
- ;;^UTILITY(U,$J,358.4,368,0)
- ;;=LENS / CATARACT / POSTOP^6^40
- ;;^UTILITY(U,$J,358.4,369,0)
- ;;=IRIS / UVEITIS^7^40
- ;;^UTILITY(U,$J,358.4,370,0)
- ;;=GLAUCOMA - OPEN ANGLE^8^40
- ;;^UTILITY(U,$J,358.4,371,0)
- ;;=GLAUCOMA - CLOSED ANGLE^9^40
- ;;^UTILITY(U,$J,358.4,372,0)
- ;;=GLAUCOMA - SECONDARY^10^40
- ;;^UTILITY(U,$J,358.4,373,0)
- ;;=RETINA - CHOROID / TUMORS / INFLAM^14^40
- ;;^UTILITY(U,$J,358.4,374,0)
- ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^40
- ;;^UTILITY(U,$J,358.4,375,0)
- ;;=RETINA - MACULA^11^40
- ;;^UTILITY(U,$J,358.4,376,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^23^40
- ;;^UTILITY(U,$J,358.4,377,0)
- ;;=PMH / OTHER^22^40
- ;;^UTILITY(U,$J,358.4,378,0)
- ;;=RETINA - VEGF INJECT DX CODES^16^40
- ;;^UTILITY(U,$J,358.4,379,0)
- ;;=RETINA - DIABETIC RETINOPATHY^13^40
- ;;^UTILITY(U,$J,358.4,380,0)
- ;;=COVID-19 & RELATED^24^40
- ;;^UTILITY(U,$J,358.4,381,0)
- ;;=NEW PATIENT^2^41
- ;;^UTILITY(U,$J,358.4,382,0)
- ;;=ESTABLISHED PATIENT^1^41
- ;;^UTILITY(U,$J,358.4,383,0)
- ;;=CONSULTATIONS^3^41
- ;;^UTILITY(U,$J,358.4,384,0)
- ;;=ESOPHAGUS^4^42
- ;;^UTILITY(U,$J,358.4,385,0)
- ;;=COLON^3^42
- ;;^UTILITY(U,$J,358.4,386,0)
- ;;=LIVER^6^42
- ;;^UTILITY(U,$J,358.4,387,0)
- ;;=PANCREAS^8^42
- ;;^UTILITY(U,$J,358.4,388,0)
- ;;=SMALL INTESTINE^11^42
- ;;^UTILITY(U,$J,358.4,389,0)
- ;;=STOMACH^12^42
- ;;^UTILITY(U,$J,358.4,390,0)
- ;;=POST SURGERY STATES^9^42
- ;;^UTILITY(U,$J,358.4,391,0)
- ;;=SYMPTOMS^14^42
- ;;^UTILITY(U,$J,358.4,392,0)
- ;;=SCREENING^10^42
- ;;^UTILITY(U,$J,358.4,393,0)
- ;;=BILIARY^2^42
- ;;^UTILITY(U,$J,358.4,394,0)
- ;;=COMOBIDITIES^15^42
- ;;^UTILITY(U,$J,358.4,395,0)
- ;;=ANORECTAL^1^42
- ;;^UTILITY(U,$J,358.4,396,0)
- ;;=INFLAMMATORY BOWEL DISEASE^5^42
- ;;^UTILITY(U,$J,358.4,397,0)
- ;;=OTHER^7^42
- ;;^UTILITY(U,$J,358.4,398,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^13^42
- ;;^UTILITY(U,$J,358.4,399,0)
- ;;=EGD^3^43
- ;;^UTILITY(U,$J,358.4,400,0)
- ;;=SMALL INTESTINE ENDOSCOPY^15^43
- ;;^UTILITY(U,$J,358.4,401,0)
- ;;=SIGMOIDOSCOPY^14^43
- ;;^UTILITY(U,$J,358.4,402,0)
- ;;=COLONOSCOPY^2^43
- ;;^UTILITY(U,$J,358.4,403,0)
- ;;=ERCP^4^43
- ;;^UTILITY(U,$J,358.4,404,0)
- ;;=G-TUBE^6^43
- ;;^UTILITY(U,$J,358.4,405,0)
- ;;=MISCELLANEOUS^10^43
- ;;^UTILITY(U,$J,358.4,406,0)
- ;;=IMMUNIZATION^8^43
- ;;^UTILITY(U,$J,358.4,407,0)
- ;;=MOTILITY^12^43
- ;;^UTILITY(U,$J,358.4,408,0)
- ;;=EUS^5^43
- ;;^UTILITY(U,$J,358.4,409,0)
- ;;=LIVER^9^43
- ;;^UTILITY(U,$J,358.4,410,0)
- ;;=MODERATE SEDATION^11^43
- ;;^UTILITY(U,$J,358.4,411,0)
- ;;=MOST COMMONLY USED^1^43
- ;;^UTILITY(U,$J,358.4,412,0)
- ;;=PROLONGED SERVICES^13^43
- ;;^UTILITY(U,$J,358.4,413,0)
- ;;=ILEOSCOPY via STOMA^7^43
- ;;^UTILITY(U,$J,358.4,414,0)
- ;;=NEW PATIENT HOME VISIT^2^44
- ;;^UTILITY(U,$J,358.4,415,0)
- ;;=ESTAB PATIENT HOME VISIT^1^44
- ;;^UTILITY(U,$J,358.4,416,0)
- ;;=PC COMMON DIAGNOSES^1^45
- ;;^UTILITY(U,$J,358.4,417,0)
- ;;=ADMINISTRATIVE TOPICS^15^45
- ;;^UTILITY(U,$J,358.4,418,0)
- ;;=ANGINA^16^45
- ;;^UTILITY(U,$J,358.4,419,0)
- ;;=ATHEROSCLEROSIS^17^45
- ;;^UTILITY(U,$J,358.4,420,0)
- ;;=CARDIOVASCULAR^18^45
- ;;^UTILITY(U,$J,358.4,421,0)
- ;;=DERMATOLOGY^22^45
- ;;^UTILITY(U,$J,358.4,422,0)
- ;;=EAR DISORDERS^24^45
- ;;^UTILITY(U,$J,358.4,423,0)
- ;;=EENT^25^45
- ;;^UTILITY(U,$J,358.4,424,0)
- ;;=ENDOCRINE/METABOLIC^26^45
- ;;^UTILITY(U,$J,358.4,425,0)
- ;;=EYE DISORDERS^27^45
- ;;^UTILITY(U,$J,358.4,426,0)
- ;;=EYE INJURY^28^45
- ;;^UTILITY(U,$J,358.4,427,0)
- ;;=GASTROENTEROLOGY^29^45
- ;;^UTILITY(U,$J,358.4,428,0)
- ;;=GU/RENAL^30^45
- ;;^UTILITY(U,$J,358.4,429,0)
- ;;=HEADACHE^31^45
- ;;^UTILITY(U,$J,358.4,430,0)
- ;;=HEART VALVE DISEASE^32^45
- ;;^UTILITY(U,$J,358.4,431,0)
- ;;=HEMATOLOGY/ONCOLOGY^33^45
- ;;^UTILITY(U,$J,358.4,432,0)
- ;;=HISTORY OF ILLNESS^34^45
- ;;^UTILITY(U,$J,358.4,433,0)
- ;;=INFECTIOUS DISEASE^35^45
- ;;^UTILITY(U,$J,358.4,434,0)
- ;;=LIVER DISEASE^36^45
- ;;^UTILITY(U,$J,358.4,435,0)
- ;;=MENTAL HEALTH^38^45
- ;;^UTILITY(U,$J,358.4,436,0)
- ;;=MOVEMENT DISORDERS^39^45
- ;;^UTILITY(U,$J,358.4,437,0)
- ;;=MUSCULOSKELETAL^40^45
- ;;^UTILITY(U,$J,358.4,438,0)
- ;;=NEUROLOGY^41^45
- ;;^UTILITY(U,$J,358.4,439,0)
- ;;=PAIN^42^45
- ;;^UTILITY(U,$J,358.4,440,0)
- ;;=PREVENTIVE HEALTH^43^45
- ;;^UTILITY(U,$J,358.4,441,0)
- ;;=PULMONARY^44^45
- ;;^UTILITY(U,$J,358.4,442,0)
- ;;=SEXUAL TRAUMA^45^45
- ;;^UTILITY(U,$J,358.4,443,0)
- ;;=SIGNS,SYMPTOMS,CONDITIONS^46^45
- ;;^UTILITY(U,$J,358.4,444,0)
- ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^45
- ;;^UTILITY(U,$J,358.4,445,0)
- ;;=SUBSTANCE DISORDERS^48^45
- ;;^UTILITY(U,$J,358.4,446,0)
- ;;=VARICOSE VEINS^50^45
- ;;^UTILITY(U,$J,358.4,447,0)
- ;;=WOMEN'S HEALTH^51^45
- ;;^UTILITY(U,$J,358.4,448,0)
- ;;=WOUNDS-INITIAL ENCOUNTER^52^45
- ;;^UTILITY(U,$J,358.4,449,0)
- ;;=COMA^20^45
- ;;^UTILITY(U,$J,358.4,450,0)
- ;;=CAUSES OF INJURY^19^45
- ;;^UTILITY(U,$J,358.4,451,0)
- ;;=DEMENTIA^21^45
- ;;^UTILITY(U,$J,358.4,452,0)
- ;;=LONG TERM CURRENT DRUG THERAPY^37^45
- ;;^UTILITY(U,$J,358.4,453,0)
- ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^45
- ;;^UTILITY(U,$J,358.4,454,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^49^45
- ;;^UTILITY(U,$J,358.4,455,0)
- ;;=ACSC ACUTE KIDNEY FAILURE^3^45
- ;;^UTILITY(U,$J,358.4,456,0)
- ;;=ACSC ANGINA^4^45
- ;;^UTILITY(U,$J,358.4,457,0)
- ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^45
- ;;^UTILITY(U,$J,358.4,458,0)
- ;;=ACSC CHF^6^45
- ;;^UTILITY(U,$J,358.4,459,0)
- ;;=ACSC DEHYDRATION^7^45
- ;;^UTILITY(U,$J,358.4,460,0)
- ;;=ACSC DIABETES TYPE 1^8^45
- ;;^UTILITY(U,$J,358.4,461,0)
- ;;=ACSC DIABETES TYPE 2^9^45
- ;;^UTILITY(U,$J,358.4,462,0)
- ;;=ACSC HYPERTENSION^10^45
- ;;^UTILITY(U,$J,358.4,463,0)
- ;;=ACSC INFECTIOUS GASTROENTERITIS^11^45
- ;;^UTILITY(U,$J,358.4,464,0)
- ;;=ACSC PNEUMONIA^12^45
- ;;^UTILITY(U,$J,358.4,465,0)
- ;;=ACSC UTI^13^45
- ;;^UTILITY(U,$J,358.4,466,0)
- ;;=ACSC VIRAL ENTERITIS^14^45
- ;;^UTILITY(U,$J,358.4,467,0)
- ;;=E-CIG/VAPE LUNG INJURY^23^45
- ;;^UTILITY(U,$J,358.4,468,0)
- ;;=TEAM CONFERENCE^20^46
- ;;^UTILITY(U,$J,358.4,469,0)
- ;;=PROCEDURE CODE^15^46
- ;;^UTILITY(U,$J,358.4,470,0)
- ;;=EDUCATION/TRAINING^6^46
- ;;^UTILITY(U,$J,358.4,471,0)
- ;;=IMMUNIZATIONS^9^46
- ;;^UTILITY(U,$J,358.4,472,0)
- ;;=OTH PREVENTIVE MEDICINE SVCS^10^46
- ;;^UTILITY(U,$J,358.4,473,0)
- ;;=SKIN TEST^18^46
- ;;^UTILITY(U,$J,358.4,474,0)
- ;;=PREVENTIVE MED-EST PT^12^46
- ;;^UTILITY(U,$J,358.4,475,0)
- ;;=PREVENTIVE MED-NEW PT^13^46
- ;;^UTILITY(U,$J,358.4,476,0)
- ;;=ADVANCED CARE PLANNING^1^46
- ;;^UTILITY(U,$J,358.4,477,0)
- ;;=IMMUNIZATION ADMINISTRATION^8^46
- ;;^UTILITY(U,$J,358.4,478,0)
- ;;=PHYSICIAN CARE PLAN OVERSIGHT^11^46
- ;;^UTILITY(U,$J,358.4,479,0)
- ;;=COVID-19 RELATED^5^46
- ;;^UTILITY(U,$J,358.4,480,0)
- ;;=CHRONIC CARE MANAGEMENT SERVICES^4^46
- ;;^UTILITY(U,$J,358.4,481,0)
- ;;=ANNUAL WELLNESS W/ PREV PLAN OF SVC^3^46
- ;;^UTILITY(U,$J,358.4,482,0)
- ;;=PROLONGED E&M SVC^16^46
- ;;^UTILITY(U,$J,358.4,483,0)
- ;;=PROLONGED SVC W/O DIRECT PT CONTACT^17^46
- ;;^UTILITY(U,$J,358.4,484,0)
- ;;=HOME HEALTH SUPERVISION^7^46
- ;;^UTILITY(U,$J,358.4,485,0)
- ;;=SMOKING/TOBACCO USE CESSATION COUNSELING^19^46
- ;;^UTILITY(U,$J,358.4,486,0)
- ;;=ALCOHOL/SUBSTANCE ABUSE SCRN/INTVN^2^46
- ;;^UTILITY(U,$J,358.4,487,0)
- ;;=PRINCIPLE CARE MANAGEMENT^14^46
- ;;^UTILITY(U,$J,358.4,488,0)
- ;;=PULSE OXIMETRY^13^47
- ;;^UTILITY(U,$J,358.4,489,0)
- ;;=BLOOD PRESSURE READING^2^47
- ;;^UTILITY(U,$J,358.4,490,0)
- ;;=SELF-CARE MANAGEMENT^14^47
- ;;^UTILITY(U,$J,358.4,491,0)
- ;;=INJECTIONS^11^47
- ;;^UTILITY(U,$J,358.4,492,0)
- ;;=INJECTION ADMINISTRATION^10^47
- ;;^UTILITY(U,$J,358.4,493,0)
- ;;=IMMUNIZATIONS^9^47
- ;;^UTILITY(U,$J,358.4,494,0)
- ;;=IMMUNIZATION ADMINISTRATION^8^47
- ;;^UTILITY(U,$J,358.4,495,0)
- ;;=USE OF INHALER^17^47
- ;;^UTILITY(U,$J,358.4,496,0)
- ;;=BLOOD DRAW(S)^1^47
- ;;^UTILITY(U,$J,358.4,497,0)
- ;;=FAMILY CONSULTATION^3^47
- ;;^UTILITY(U,$J,358.4,498,0)
- ;;=WOUND CARE/TUBE CHANGE^18^47
- ;;^UTILITY(U,$J,358.4,499,0)
- ;;=INSERT CATHETER^12^47
- ;;^UTILITY(U,$J,358.4,500,0)
- ;;=SKIN TEST^15^47
- ;;^UTILITY(U,$J,358.4,501,0)
- ;;=HANDLING OF SPECIMEN(S)^4^47
- ;;^UTILITY(U,$J,358.4,502,0)
- ;;=TEAM CONFERENCE^16^47
- ;;^UTILITY(U,$J,358.4,503,0)
- ;;=HOME HEALTH PROCEDURE/SERVICE^5^47
- ;;^UTILITY(U,$J,358.4,504,0)
- ;;=HOME INFUSION PROC/SVC^6^47
- ;;^UTILITY(U,$J,358.4,505,0)
- ;;=HOME VISITS^7^47
- ;;^UTILITY(U,$J,358.4,506,0)
- ;;=PRESSURE ULCER^14^48
- ;;^UTILITY(U,$J,358.4,507,0)
- ;;=SKIN^19^48
- ;;^UTILITY(U,$J,358.4,508,0)
- ;;=SIGNS AND SYMPTOMS^1^48
- ;;^UTILITY(U,$J,358.4,509,0)
- ;;=CARDIO/VASCULAR^2^48
- ;;^UTILITY(U,$J,358.4,510,0)
- ;;=COUNSELING^3^48
- ;;^UTILITY(U,$J,358.4,511,0)
- ;;=ENDOCRINE,METABOLIC,NUTRITION^4^48
- ;;^UTILITY(U,$J,358.4,512,0)
- ;;=ENT^5^48
- ;;^UTILITY(U,$J,358.4,513,0)
- ;;=GASTROINTESTINAL^6^48
- ;;^UTILITY(U,$J,358.4,514,0)
- ;;=GENITOURINARY & RENAL^7^48
- ;;^UTILITY(U,$J,358.4,515,0)
- ;;=HEPATITIS^8^48
- ;;^UTILITY(U,$J,358.4,516,0)
- ;;=IMMUNIZATIONS^9^48
- ;;^UTILITY(U,$J,358.4,517,0)
- ;;=MUSCULOSKELETAL^10^48
- ;;^UTILITY(U,$J,358.4,518,0)
- ;;=NEUROLOGY^11^48
- ;;^UTILITY(U,$J,358.4,519,0)
- ;;=NURSING MISCELLANEOUS^12^48
- ;;^UTILITY(U,$J,358.4,520,0)
- ;;=PREVENTIVE MEDICINE^15^48
- ;;^UTILITY(U,$J,358.4,521,0)
- ;;=PULMONARY/RESPIRATORY^16^48
- ;;^UTILITY(U,$J,358.4,522,0)
- ;;=PSYCHIATRIC^17^48
- ;;^UTILITY(U,$J,358.4,523,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^20^48
- ;;^UTILITY(U,$J,358.4,524,0)
- ;;=OSTOMY STATUS^13^48
- ;;^UTILITY(U,$J,358.4,525,0)
- ;;=SCREENING^18^48
- ;;^UTILITY(U,$J,358.4,526,0)
- ;;=ORTHOTIC DEVICES^6^49
- ;;^UTILITY(U,$J,358.4,527,0)
- ;;=THERAPY EVALUATIONS^10^49
- ;;^UTILITY(U,$J,358.4,528,0)
- ;;=HBPC HOME THERAPY SVC (HBPC PT,OT,SLP)^5^49
- ;;^UTILITY(U,$J,358.4,529,0)
- ;;=KT HOME HEALTH SERVICES^5^49
- ;;^UTILITY(U,$J,358.4,530,0)
- ;;=SPEECH/LANG HOME HEALTH SERVICE^8^49
- ;;^UTILITY(U,$J,358.4,531,0)
- ;;=DEVICES/SUPPLIES^3^49
- ;;^UTILITY(U,$J,358.4,532,0)
- ;;=TENS^9^49
- ;;^UTILITY(U,$J,358.4,533,0)
- ;;=ADAPTIVE BEHAVIOR ASSESSMENTS^1^49
- ;;^UTILITY(U,$J,358.4,534,0)
- ;;=ADAPTIVE BEHAVIOR TREATMENT^2^49
- ;;^UTILITY(U,$J,358.4,535,0)
- ;;=PROCEDURES^7^49
- ;;^UTILITY(U,$J,358.4,536,0)
- ;;=FUNCTIONAL OUTCOME ASSESSMENT^4^49
- ;;^UTILITY(U,$J,358.4,537,0)
- ;;=AMPUTATION STATUS^1^50
- ;;^UTILITY(U,$J,358.4,538,0)
- ;;=BRAIN DISORDERS^2^50
- ;;^UTILITY(U,$J,358.4,539,0)
- ;;=CARDIOPULMONARY^4^50
- ;;^UTILITY(U,$J,358.4,540,0)
- ;;=COMPLICATIONS DUE TO^5^50
- ;;^UTILITY(U,$J,358.4,541,0)
- ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^50
- ;;^UTILITY(U,$J,358.4,542,0)
- ;;=Z CODES^21^50
- ;;^UTILITY(U,$J,358.4,543,0)
- ;;=BRAIN INJURY - TRAUMATIC^3^50
- ;;^UTILITY(U,$J,358.4,544,0)
- ;;=FEMUR/THIGH/KNEE FRACTURE^7^50
- ;;^UTILITY(U,$J,358.4,545,0)
- ;;=FOOT/TOE/ANKLE FRACTURE^8^50
- ;;^UTILITY(U,$J,358.4,546,0)
- ;;=HAND/FINGER FRACTURE^9^50
- ;;^UTILITY(U,$J,358.4,547,0)
- ;;=HIP/PELVIS FRACTURE^10^50
- ;;^UTILITY(U,$J,358.4,548,0)
- ;;=HUMERUS/SHOULDER FRACTURE^11^50
- ;;^UTILITY(U,$J,358.4,549,0)
- ;;=TIBIA/FIBULA FRACTURE^19^50
- ;;^UTILITY(U,$J,358.4,550,0)
- ;;=SPINE FRACTURE^16^50
- ;;^UTILITY(U,$J,358.4,551,0)
- ;;=WRIST/FOREARM FRACTURE^20^50
- ;;^UTILITY(U,$J,358.4,552,0)
- ;;=OTHER FRACTURE^14^50
- ;;^UTILITY(U,$J,358.4,553,0)
- ;;=PAIN^15^50
- ;;^UTILITY(U,$J,358.4,554,0)
- ;;=SPINAL CONDITIONS^17^50
- ;;^UTILITY(U,$J,358.4,555,0)
- ;;=SYMPTOMS^18^50
- ;;^UTILITY(U,$J,358.4,556,0)
- ;;=FALLS^6^50
- ;;^UTILITY(U,$J,358.4,557,0)
- ;;=NERVES^13^50
- ;;^UTILITY(U,$J,358.4,558,0)
- ;;=OBSERVATION-INIT^10^51
- ;;^UTILITY(U,$J,358.4,559,0)
- ;;=BEDSIDE VISIT-INITIAL CARE^2^51
- ;;^UTILITY(U,$J,358.4,560,0)
- ;;=CONSULTATIONS-INPT^4^51
- ;;^UTILITY(U,$J,358.4,561,0)
- ;;=OBSERVATION-DISCHARGE^12^51
- ;;^UTILITY(U,$J,358.4,562,0)
- ;;=BEDSIDE VISITS-DAILY VISITS^3^51
- ;;^UTILITY(U,$J,358.4,563,0)
- ;;=ADMIT & DISCHARGE SAME DAY^1^51
- ;;^UTILITY(U,$J,358.4,564,0)
- ;;=DISCHARGE DAY CODES^6^51
- ;;^UTILITY(U,$J,358.4,565,0)
- ;;=OBSERVATION-SUBSQ^11^51
- ;;^UTILITY(U,$J,358.4,566,0)
- ;;=POST-OP VISIT^13^51
- ;;^UTILITY(U,$J,358.4,567,0)
- ;;=CRITICAL CARE^5^51
- ;;^UTILITY(U,$J,358.4,568,0)
- ;;=NURS FAC CARE-INIT (SNF,ICF,LTCF)^7^51
- ;;^UTILITY(U,$J,358.4,569,0)
- ;;=NURS FAC CARE-SUBSQ (SNF,ICF,LTCF)^8^51
- ;;^UTILITY(U,$J,358.4,570,0)
- ;;=NURS FAC CARE-D/C SVC (SNF,ICF,LTCF)^9^51
- ;;^UTILITY(U,$J,358.4,571,0)
- ;;=INPT VENT MGMT^4^52
- ;;^UTILITY(U,$J,358.4,572,0)
- ;;=CRITICAL CARE^2^52
- ;;^UTILITY(U,$J,358.4,573,0)
- ;;=TEAM CONFERENCE^8^52
- ;;^UTILITY(U,$J,358.4,574,0)
- ;;=PROLONGED SERVICES^7^52
- ;;^UTILITY(U,$J,358.4,575,0)
- ;;=BEDSIDE PROCEDURES^1^52
- ;;^UTILITY(U,$J,358.4,576,0)
- ;;=MODERATE SEDATION^6^52
- ;;^UTILITY(U,$J,358.4,577,0)
- ;;=MED MANAGEMENT^5^52
- ;;^UTILITY(U,$J,358.4,578,0)
- ;;=IMMUNIZATIONS^3^52
- ;;^UTILITY(U,$J,358.4,579,0)
- ;;=SIGNS/SYMPTOMS^16^53
- ;;^UTILITY(U,$J,358.4,580,0)
- ;;=PAIN^14^53
- ;;^UTILITY(U,$J,358.4,581,0)
- ;;=MASS^10^53
- ;;^UTILITY(U,$J,358.4,582,0)
- ;;=COMPLICATIONS^3^53
- ;;^UTILITY(U,$J,358.4,583,0)
- ;;=CARDIOVASCULAR^2^53
- ;;^UTILITY(U,$J,358.4,584,0)
- ;;=RESPIRATORY^15^53
- ;;^UTILITY(U,$J,358.4,585,0)
- ;;=GASTROENTEROLOGY^5^53
- ;;^UTILITY(U,$J,358.4,586,0)
- ;;=GENITORURINARY^6^53
- ;;^UTILITY(U,$J,358.4,587,0)
- ;;=MUSCULOSKELETAL^12^53
- ;;^UTILITY(U,$J,358.4,588,0)
- ;;=NEUROLOGY^13^53
- ;;^UTILITY(U,$J,358.4,589,0)
- ;;=HEMATOLOGY/ONCOLOGY^7^53
- ;;^UTILITY(U,$J,358.4,590,0)
- ;;=INFECTIOUS DISEASE^9^53
- ;;^UTILITY(U,$J,358.4,591,0)
- ;;=SUBSTANCE ABUSE-ALCOHOL^18^53
- ;;^UTILITY(U,$J,358.4,592,0)
- ;;=SUBSTANCE ABUSE-AMPHETAMINE^19^53
- ;;^UTILITY(U,$J,358.4,593,0)
- ;;=SUBSTANCE ABUSE-CANNABIS^20^53
- ;;^UTILITY(U,$J,358.4,594,0)
- ;;=SUBSTANCE ABUSE-COCAINE^21^53
- ;;^UTILITY(U,$J,358.4,595,0)
- ;;=SUBSTANCE ABUSE-HALLUCINOGEN^22^53
- ;;^UTILITY(U,$J,358.4,596,0)
- ;;=SUBSTANCE ABUSE-INHALANT^23^53
- ;;^UTILITY(U,$J,358.4,597,0)
- ;;=SUBSTANCE ABUSE-OPIOID^24^53
- ;;^UTILITY(U,$J,358.4,598,0)
- ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^25^53
- ;;^UTILITY(U,$J,358.4,599,0)
- ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^26^53
- ;;^UTILITY(U,$J,358.4,600,0)
- ;;=SUBSTANCE ABUSE-TOBACCO^27^53
- ;;^UTILITY(U,$J,358.4,601,0)
- ;;=ENDOCRINE^4^53
- ;;^UTILITY(U,$J,358.4,602,0)
- ;;=ICU^8^53
- ;;^UTILITY(U,$J,358.4,603,0)
- ;;=SUICIDAL IDEATIONS/ATTEMPTS^28^53
- ;;^UTILITY(U,$J,358.4,604,0)
- ;;=MISCELLANEOUS^11^53
- ;;^UTILITY(U,$J,358.4,605,0)
- ;;=GENERAL IM^1^53
- ;;^UTILITY(U,$J,358.4,606,0)
- ;;=SOCIAL DETERMINANTS OF HEALTH^17^53
- ;;^UTILITY(U,$J,358.4,607,0)
- ;;=NEW PATIENT^2^54
- ;;^UTILITY(U,$J,358.4,608,0)
- ;;=ESTABLISHED PATIENT^1^54
- ;;^UTILITY(U,$J,358.4,609,0)
- ;;=CONSULTATIONS^3^54
- ;;^UTILITY(U,$J,358.4,610,0)
- ;;=PREVENTIVE MED-EST PT^4^54
- ;;^UTILITY(U,$J,358.4,611,0)
- ;;=PREVENTIVE MED-NEW PT^5^54
- ;;^UTILITY(U,$J,358.4,612,0)
- ;;=TRANSITIONAL CARE MGNT (TCM)^6^54
- ;;^UTILITY(U,$J,358.4,613,0)
- ;;=IMMUNIZATIONS^6^55
- ;;^UTILITY(U,$J,358.4,614,0)
- ;;=INJECTION^7^55
- ;;^UTILITY(U,$J,358.4,615,0)
- ;;=SKIN TESTS^15^55
- ;;^UTILITY(U,$J,358.4,616,0)
- ;;=NURSING PROCEDURES^9^55
- ;;^UTILITY(U,$J,358.4,617,0)
- ;;=MINOR PROCEDURES^8^55
- ;;^UTILITY(U,$J,358.4,618,0)
- ;;=SPLINTS^16^55
- ;;^UTILITY(U,$J,358.4,619,0)
- ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^14^55
- ;;^UTILITY(U,$J,358.4,620,0)
- ;;=REPAIR-SIMPLE FACE,MUCOUS^13^55
- ;;^UTILITY(U,$J,358.4,621,0)
- ;;=IMMUNIZATION ADMIN^5^55
- ;;^UTILITY(U,$J,358.4,622,0)
- ;;=BEHAVIOR CHANGE INTERVENTION^2^55
- ;;^UTILITY(U,$J,358.4,623,0)
- ;;=ADVANCE CARE PLANNING^1^55
- ;;^UTILITY(U,$J,358.4,624,0)
- ;;=PREVENTIVE MED-EST PT^10^55
- ;;^UTILITY(U,$J,358.4,625,0)
- ;;=PREVENTIVE MED-NEW PT^11^55
- ;;^UTILITY(U,$J,358.4,626,0)
- ;;=E-CONSULT REFERRAL^4^55
- ;;^UTILITY(U,$J,358.4,627,0)
- ;;=COVID-19 RELATED^3^55
- ;;^UTILITY(U,$J,358.4,628,0)
- ;;=PROLONGED SERVICES^12^55
- ;;^UTILITY(U,$J,358.4,629,0)
- ;;=PC COMMON DIAGNOSES^1^56
- ;;^UTILITY(U,$J,358.4,630,0)
- ;;=ADMINISTRATIVE TOPICS^15^56
- ;;^UTILITY(U,$J,358.4,631,0)
- ;;=ANGINA^16^56
- ;;^UTILITY(U,$J,358.4,632,0)
- ;;=ATHEROSCLEROSIS^17^56
- ;;^UTILITY(U,$J,358.4,633,0)
- ;;=CARDIOVASCULAR^18^56
- ;;^UTILITY(U,$J,358.4,634,0)
- ;;=DERMATOLOGY^22^56
- ;;^UTILITY(U,$J,358.4,635,0)
- ;;=EAR DISORDERS^24^56
- ;;^UTILITY(U,$J,358.4,636,0)
- ;;=EENT^25^56
- ;;^UTILITY(U,$J,358.4,637,0)
- ;;=ENDOCRINE/METABOLIC^26^56
- ;;^UTILITY(U,$J,358.4,638,0)
- ;;=EYE DISORDERS^27^56
- ;;^UTILITY(U,$J,358.4,639,0)
- ;;=EYE INJURY^28^56
- ;;^UTILITY(U,$J,358.4,640,0)
- ;;=GASTROENTEROLOGY^29^56
- ;;^UTILITY(U,$J,358.4,641,0)
- ;;=GU/RENAL^30^56
- ;;^UTILITY(U,$J,358.4,642,0)
- ;;=HEADACHE^31^56
- ;;^UTILITY(U,$J,358.4,643,0)
- ;;=HEART VALVE DISEASE^32^56
- ;;^UTILITY(U,$J,358.4,644,0)
- ;;=HEMATOLOGY/ONCOLOGY^33^56
- ;;^UTILITY(U,$J,358.4,645,0)
- ;;=HISTORY OF ILLNESS^34^56
- ;;^UTILITY(U,$J,358.4,646,0)
- ;;=INFECTIOUS DISEASE^35^56
- ;;^UTILITY(U,$J,358.4,647,0)
- ;;=LIVER DISEASE^36^56
- ;;^UTILITY(U,$J,358.4,648,0)
- ;;=MENTAL HEALTH^38^56
- ;;^UTILITY(U,$J,358.4,649,0)
- ;;=MOVEMENT DISORDERS^39^56
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0BF 19755 printed Mar 13, 2025@20:50:02 Page 2
- IBDEI0BF ; ; 01-AUG-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,326,0)
- +2 ;;=PMH / OTHER^22^37
- +3 ;;^UTILITY(U,$J,358.4,327,0)
- +4 ;;=RETINA - VEGF INJECT DX CODES^16^37
- +5 ;;^UTILITY(U,$J,358.4,328,0)
- +6 ;;=RETINA - DIABETIC RETINOPATHY^13^37
- +7 ;;^UTILITY(U,$J,358.4,329,0)
- +8 ;;=COVID-19 & RELATED^24^37
- +9 ;;^UTILITY(U,$J,358.4,330,0)
- +10 ;;=NEW PATIENT^3^38
- +11 ;;^UTILITY(U,$J,358.4,331,0)
- +12 ;;=ESTABLISHED PATIENT^2^38
- +13 ;;^UTILITY(U,$J,358.4,332,0)
- +14 ;;=CONSULTS - OUTPT^4^38
- +15 ;;^UTILITY(U,$J,358.4,333,0)
- +16 ;;=EYE CODES^1^38
- +17 ;;^UTILITY(U,$J,358.4,334,0)
- +18 ;;=CONSULTS - INPT^5^38
- +19 ;;^UTILITY(U,$J,358.4,335,0)
- +20 ;;=HOSPITAL CARE - INITIAL^6^38
- +21 ;;^UTILITY(U,$J,358.4,336,0)
- +22 ;;=HOSPITAL CARE - SUBSEQUENT^7^38
- +23 ;;^UTILITY(U,$J,358.4,337,0)
- +24 ;;=HOSPITAL CARE - DISCHARGE^8^38
- +25 ;;^UTILITY(U,$J,358.4,338,0)
- +26 ;;=OBSERVATION CARE - INITIAL^9^38
- +27 ;;^UTILITY(U,$J,358.4,339,0)
- +28 ;;=OBSERVATION CARE - SUBSEQUENT^10^38
- +29 ;;^UTILITY(U,$J,358.4,340,0)
- +30 ;;=OBSERVATION CARE - DISCHARGE^11^38
- +31 ;;^UTILITY(U,$J,358.4,341,0)
- +32 ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^38
- +33 ;;^UTILITY(U,$J,358.4,342,0)
- +34 ;;=EEF Version 2022 July^13^38
- +35 ;;^UTILITY(U,$J,358.4,343,0)
- +36 ;;=PROC - LID / LACRIMAL^7^39
- +37 ;;^UTILITY(U,$J,358.4,344,0)
- +38 ;;=PROC - LASER / CRYO^10^39
- +39 ;;^UTILITY(U,$J,358.4,345,0)
- +40 ;;=PROC - CORNEA / CONJ^6^39
- +41 ;;^UTILITY(U,$J,358.4,346,0)
- +42 ;;=MEDICATIONS^12^39
- +43 ;;^UTILITY(U,$J,358.4,347,0)
- +44 ;;=PROC - INJECTIONS / ALL^9^39
- +45 ;;^UTILITY(U,$J,358.4,348,0)
- +46 ;;=IMAGE / PHOTOS^2^39
- +47 ;;^UTILITY(U,$J,358.4,349,0)
- +48 ;;=REFRACT / GLASSES / CL^1^39
- +49 ;;^UTILITY(U,$J,358.4,350,0)
- +50 ;;=TEST - CATARACT / CORNEA^4^39
- +51 ;;^UTILITY(U,$J,358.4,351,0)
- +52 ;;=TEST - GLAUCOMA^3^39
- +53 ;;^UTILITY(U,$J,358.4,352,0)
- +54 ;;=TEST - OTHER^5^39
- +55 ;;^UTILITY(U,$J,358.4,353,0)
- +56 ;;=EDUCATION / COUNSELING^13^39
- +57 ;;^UTILITY(U,$J,358.4,354,0)
- +58 ;;=EYE SURGERY CODES^11^39
- +59 ;;^UTILITY(U,$J,358.4,355,0)
- +60 ;;=PROC - INJECTIONS / VEGF^8^39
- +61 ;;^UTILITY(U,$J,358.4,356,0)
- +62 ;;=TEST - ERG / VEP^14^39
- +63 ;;^UTILITY(U,$J,358.4,357,0)
- +64 ;;=LOW VISION / BLINDNESS^21^40
- +65 ;;^UTILITY(U,$J,358.4,358,0)
- +66 ;;=RETINA - VASCULAR^12^40
- +67 ;;^UTILITY(U,$J,358.4,359,0)
- +68 ;;=EYELIDS / LASHES^2^40
- +69 ;;^UTILITY(U,$J,358.4,360,0)
- +70 ;;=NEURO / STRABISMUS^18^40
- +71 ;;^UTILITY(U,$J,358.4,361,0)
- +72 ;;=ORBIT - PLASTICS^20^40
- +73 ;;^UTILITY(U,$J,358.4,362,0)
- +74 ;;=VITREOUS^17^40
- +75 ;;^UTILITY(U,$J,358.4,363,0)
- +76 ;;=ORBIT - TRAUMA^19^40
- +77 ;;^UTILITY(U,$J,358.4,364,0)
- +78 ;;=LACRIMAL / NLD / NEOPLASMS^3^40
- +79 ;;^UTILITY(U,$J,358.4,365,0)
- +80 ;;=MOST FREQUENT^1^40
- +81 ;;^UTILITY(U,$J,358.4,366,0)
- +82 ;;=CONJUNCTIVA / SCLERA^4^40
- +83 ;;^UTILITY(U,$J,358.4,367,0)
- +84 ;;=CORNEA / ULCER^5^40
- +85 ;;^UTILITY(U,$J,358.4,368,0)
- +86 ;;=LENS / CATARACT / POSTOP^6^40
- +87 ;;^UTILITY(U,$J,358.4,369,0)
- +88 ;;=IRIS / UVEITIS^7^40
- +89 ;;^UTILITY(U,$J,358.4,370,0)
- +90 ;;=GLAUCOMA - OPEN ANGLE^8^40
- +91 ;;^UTILITY(U,$J,358.4,371,0)
- +92 ;;=GLAUCOMA - CLOSED ANGLE^9^40
- +93 ;;^UTILITY(U,$J,358.4,372,0)
- +94 ;;=GLAUCOMA - SECONDARY^10^40
- +95 ;;^UTILITY(U,$J,358.4,373,0)
- +96 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^40
- +97 ;;^UTILITY(U,$J,358.4,374,0)
- +98 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^40
- +99 ;;^UTILITY(U,$J,358.4,375,0)
- +100 ;;=RETINA - MACULA^11^40
- +101 ;;^UTILITY(U,$J,358.4,376,0)
- +102 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^40
- +103 ;;^UTILITY(U,$J,358.4,377,0)
- +104 ;;=PMH / OTHER^22^40
- +105 ;;^UTILITY(U,$J,358.4,378,0)
- +106 ;;=RETINA - VEGF INJECT DX CODES^16^40
- +107 ;;^UTILITY(U,$J,358.4,379,0)
- +108 ;;=RETINA - DIABETIC RETINOPATHY^13^40
- +109 ;;^UTILITY(U,$J,358.4,380,0)
- +110 ;;=COVID-19 & RELATED^24^40
- +111 ;;^UTILITY(U,$J,358.4,381,0)
- +112 ;;=NEW PATIENT^2^41
- +113 ;;^UTILITY(U,$J,358.4,382,0)
- +114 ;;=ESTABLISHED PATIENT^1^41
- +115 ;;^UTILITY(U,$J,358.4,383,0)
- +116 ;;=CONSULTATIONS^3^41
- +117 ;;^UTILITY(U,$J,358.4,384,0)
- +118 ;;=ESOPHAGUS^4^42
- +119 ;;^UTILITY(U,$J,358.4,385,0)
- +120 ;;=COLON^3^42
- +121 ;;^UTILITY(U,$J,358.4,386,0)
- +122 ;;=LIVER^6^42
- +123 ;;^UTILITY(U,$J,358.4,387,0)
- +124 ;;=PANCREAS^8^42
- +125 ;;^UTILITY(U,$J,358.4,388,0)
- +126 ;;=SMALL INTESTINE^11^42
- +127 ;;^UTILITY(U,$J,358.4,389,0)
- +128 ;;=STOMACH^12^42
- +129 ;;^UTILITY(U,$J,358.4,390,0)
- +130 ;;=POST SURGERY STATES^9^42
- +131 ;;^UTILITY(U,$J,358.4,391,0)
- +132 ;;=SYMPTOMS^14^42
- +133 ;;^UTILITY(U,$J,358.4,392,0)
- +134 ;;=SCREENING^10^42
- +135 ;;^UTILITY(U,$J,358.4,393,0)
- +136 ;;=BILIARY^2^42
- +137 ;;^UTILITY(U,$J,358.4,394,0)
- +138 ;;=COMOBIDITIES^15^42
- +139 ;;^UTILITY(U,$J,358.4,395,0)
- +140 ;;=ANORECTAL^1^42
- +141 ;;^UTILITY(U,$J,358.4,396,0)
- +142 ;;=INFLAMMATORY BOWEL DISEASE^5^42
- +143 ;;^UTILITY(U,$J,358.4,397,0)
- +144 ;;=OTHER^7^42
- +145 ;;^UTILITY(U,$J,358.4,398,0)
- +146 ;;=SUICIDE IDEATIONS/ATTEMPTS^13^42
- +147 ;;^UTILITY(U,$J,358.4,399,0)
- +148 ;;=EGD^3^43
- +149 ;;^UTILITY(U,$J,358.4,400,0)
- +150 ;;=SMALL INTESTINE ENDOSCOPY^15^43
- +151 ;;^UTILITY(U,$J,358.4,401,0)
- +152 ;;=SIGMOIDOSCOPY^14^43
- +153 ;;^UTILITY(U,$J,358.4,402,0)
- +154 ;;=COLONOSCOPY^2^43
- +155 ;;^UTILITY(U,$J,358.4,403,0)
- +156 ;;=ERCP^4^43
- +157 ;;^UTILITY(U,$J,358.4,404,0)
- +158 ;;=G-TUBE^6^43
- +159 ;;^UTILITY(U,$J,358.4,405,0)
- +160 ;;=MISCELLANEOUS^10^43
- +161 ;;^UTILITY(U,$J,358.4,406,0)
- +162 ;;=IMMUNIZATION^8^43
- +163 ;;^UTILITY(U,$J,358.4,407,0)
- +164 ;;=MOTILITY^12^43
- +165 ;;^UTILITY(U,$J,358.4,408,0)
- +166 ;;=EUS^5^43
- +167 ;;^UTILITY(U,$J,358.4,409,0)
- +168 ;;=LIVER^9^43
- +169 ;;^UTILITY(U,$J,358.4,410,0)
- +170 ;;=MODERATE SEDATION^11^43
- +171 ;;^UTILITY(U,$J,358.4,411,0)
- +172 ;;=MOST COMMONLY USED^1^43
- +173 ;;^UTILITY(U,$J,358.4,412,0)
- +174 ;;=PROLONGED SERVICES^13^43
- +175 ;;^UTILITY(U,$J,358.4,413,0)
- +176 ;;=ILEOSCOPY via STOMA^7^43
- +177 ;;^UTILITY(U,$J,358.4,414,0)
- +178 ;;=NEW PATIENT HOME VISIT^2^44
- +179 ;;^UTILITY(U,$J,358.4,415,0)
- +180 ;;=ESTAB PATIENT HOME VISIT^1^44
- +181 ;;^UTILITY(U,$J,358.4,416,0)
- +182 ;;=PC COMMON DIAGNOSES^1^45
- +183 ;;^UTILITY(U,$J,358.4,417,0)
- +184 ;;=ADMINISTRATIVE TOPICS^15^45
- +185 ;;^UTILITY(U,$J,358.4,418,0)
- +186 ;;=ANGINA^16^45
- +187 ;;^UTILITY(U,$J,358.4,419,0)
- +188 ;;=ATHEROSCLEROSIS^17^45
- +189 ;;^UTILITY(U,$J,358.4,420,0)
- +190 ;;=CARDIOVASCULAR^18^45
- +191 ;;^UTILITY(U,$J,358.4,421,0)
- +192 ;;=DERMATOLOGY^22^45
- +193 ;;^UTILITY(U,$J,358.4,422,0)
- +194 ;;=EAR DISORDERS^24^45
- +195 ;;^UTILITY(U,$J,358.4,423,0)
- +196 ;;=EENT^25^45
- +197 ;;^UTILITY(U,$J,358.4,424,0)
- +198 ;;=ENDOCRINE/METABOLIC^26^45
- +199 ;;^UTILITY(U,$J,358.4,425,0)
- +200 ;;=EYE DISORDERS^27^45
- +201 ;;^UTILITY(U,$J,358.4,426,0)
- +202 ;;=EYE INJURY^28^45
- +203 ;;^UTILITY(U,$J,358.4,427,0)
- +204 ;;=GASTROENTEROLOGY^29^45
- +205 ;;^UTILITY(U,$J,358.4,428,0)
- +206 ;;=GU/RENAL^30^45
- +207 ;;^UTILITY(U,$J,358.4,429,0)
- +208 ;;=HEADACHE^31^45
- +209 ;;^UTILITY(U,$J,358.4,430,0)
- +210 ;;=HEART VALVE DISEASE^32^45
- +211 ;;^UTILITY(U,$J,358.4,431,0)
- +212 ;;=HEMATOLOGY/ONCOLOGY^33^45
- +213 ;;^UTILITY(U,$J,358.4,432,0)
- +214 ;;=HISTORY OF ILLNESS^34^45
- +215 ;;^UTILITY(U,$J,358.4,433,0)
- +216 ;;=INFECTIOUS DISEASE^35^45
- +217 ;;^UTILITY(U,$J,358.4,434,0)
- +218 ;;=LIVER DISEASE^36^45
- +219 ;;^UTILITY(U,$J,358.4,435,0)
- +220 ;;=MENTAL HEALTH^38^45
- +221 ;;^UTILITY(U,$J,358.4,436,0)
- +222 ;;=MOVEMENT DISORDERS^39^45
- +223 ;;^UTILITY(U,$J,358.4,437,0)
- +224 ;;=MUSCULOSKELETAL^40^45
- +225 ;;^UTILITY(U,$J,358.4,438,0)
- +226 ;;=NEUROLOGY^41^45
- +227 ;;^UTILITY(U,$J,358.4,439,0)
- +228 ;;=PAIN^42^45
- +229 ;;^UTILITY(U,$J,358.4,440,0)
- +230 ;;=PREVENTIVE HEALTH^43^45
- +231 ;;^UTILITY(U,$J,358.4,441,0)
- +232 ;;=PULMONARY^44^45
- +233 ;;^UTILITY(U,$J,358.4,442,0)
- +234 ;;=SEXUAL TRAUMA^45^45
- +235 ;;^UTILITY(U,$J,358.4,443,0)
- +236 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^45
- +237 ;;^UTILITY(U,$J,358.4,444,0)
- +238 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^45
- +239 ;;^UTILITY(U,$J,358.4,445,0)
- +240 ;;=SUBSTANCE DISORDERS^48^45
- +241 ;;^UTILITY(U,$J,358.4,446,0)
- +242 ;;=VARICOSE VEINS^50^45
- +243 ;;^UTILITY(U,$J,358.4,447,0)
- +244 ;;=WOMEN'S HEALTH^51^45
- +245 ;;^UTILITY(U,$J,358.4,448,0)
- +246 ;;=WOUNDS-INITIAL ENCOUNTER^52^45
- +247 ;;^UTILITY(U,$J,358.4,449,0)
- +248 ;;=COMA^20^45
- +249 ;;^UTILITY(U,$J,358.4,450,0)
- +250 ;;=CAUSES OF INJURY^19^45
- +251 ;;^UTILITY(U,$J,358.4,451,0)
- +252 ;;=DEMENTIA^21^45
- +253 ;;^UTILITY(U,$J,358.4,452,0)
- +254 ;;=LONG TERM CURRENT DRUG THERAPY^37^45
- +255 ;;^UTILITY(U,$J,358.4,453,0)
- +256 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^45
- +257 ;;^UTILITY(U,$J,358.4,454,0)
- +258 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^45
- +259 ;;^UTILITY(U,$J,358.4,455,0)
- +260 ;;=ACSC ACUTE KIDNEY FAILURE^3^45
- +261 ;;^UTILITY(U,$J,358.4,456,0)
- +262 ;;=ACSC ANGINA^4^45
- +263 ;;^UTILITY(U,$J,358.4,457,0)
- +264 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^45
- +265 ;;^UTILITY(U,$J,358.4,458,0)
- +266 ;;=ACSC CHF^6^45
- +267 ;;^UTILITY(U,$J,358.4,459,0)
- +268 ;;=ACSC DEHYDRATION^7^45
- +269 ;;^UTILITY(U,$J,358.4,460,0)
- +270 ;;=ACSC DIABETES TYPE 1^8^45
- +271 ;;^UTILITY(U,$J,358.4,461,0)
- +272 ;;=ACSC DIABETES TYPE 2^9^45
- +273 ;;^UTILITY(U,$J,358.4,462,0)
- +274 ;;=ACSC HYPERTENSION^10^45
- +275 ;;^UTILITY(U,$J,358.4,463,0)
- +276 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^45
- +277 ;;^UTILITY(U,$J,358.4,464,0)
- +278 ;;=ACSC PNEUMONIA^12^45
- +279 ;;^UTILITY(U,$J,358.4,465,0)
- +280 ;;=ACSC UTI^13^45
- +281 ;;^UTILITY(U,$J,358.4,466,0)
- +282 ;;=ACSC VIRAL ENTERITIS^14^45
- +283 ;;^UTILITY(U,$J,358.4,467,0)
- +284 ;;=E-CIG/VAPE LUNG INJURY^23^45
- +285 ;;^UTILITY(U,$J,358.4,468,0)
- +286 ;;=TEAM CONFERENCE^20^46
- +287 ;;^UTILITY(U,$J,358.4,469,0)
- +288 ;;=PROCEDURE CODE^15^46
- +289 ;;^UTILITY(U,$J,358.4,470,0)
- +290 ;;=EDUCATION/TRAINING^6^46
- +291 ;;^UTILITY(U,$J,358.4,471,0)
- +292 ;;=IMMUNIZATIONS^9^46
- +293 ;;^UTILITY(U,$J,358.4,472,0)
- +294 ;;=OTH PREVENTIVE MEDICINE SVCS^10^46
- +295 ;;^UTILITY(U,$J,358.4,473,0)
- +296 ;;=SKIN TEST^18^46
- +297 ;;^UTILITY(U,$J,358.4,474,0)
- +298 ;;=PREVENTIVE MED-EST PT^12^46
- +299 ;;^UTILITY(U,$J,358.4,475,0)
- +300 ;;=PREVENTIVE MED-NEW PT^13^46
- +301 ;;^UTILITY(U,$J,358.4,476,0)
- +302 ;;=ADVANCED CARE PLANNING^1^46
- +303 ;;^UTILITY(U,$J,358.4,477,0)
- +304 ;;=IMMUNIZATION ADMINISTRATION^8^46
- +305 ;;^UTILITY(U,$J,358.4,478,0)
- +306 ;;=PHYSICIAN CARE PLAN OVERSIGHT^11^46
- +307 ;;^UTILITY(U,$J,358.4,479,0)
- +308 ;;=COVID-19 RELATED^5^46
- +309 ;;^UTILITY(U,$J,358.4,480,0)
- +310 ;;=CHRONIC CARE MANAGEMENT SERVICES^4^46
- +311 ;;^UTILITY(U,$J,358.4,481,0)
- +312 ;;=ANNUAL WELLNESS W/ PREV PLAN OF SVC^3^46
- +313 ;;^UTILITY(U,$J,358.4,482,0)
- +314 ;;=PROLONGED E&M SVC^16^46
- +315 ;;^UTILITY(U,$J,358.4,483,0)
- +316 ;;=PROLONGED SVC W/O DIRECT PT CONTACT^17^46
- +317 ;;^UTILITY(U,$J,358.4,484,0)
- +318 ;;=HOME HEALTH SUPERVISION^7^46
- +319 ;;^UTILITY(U,$J,358.4,485,0)
- +320 ;;=SMOKING/TOBACCO USE CESSATION COUNSELING^19^46
- +321 ;;^UTILITY(U,$J,358.4,486,0)
- +322 ;;=ALCOHOL/SUBSTANCE ABUSE SCRN/INTVN^2^46
- +323 ;;^UTILITY(U,$J,358.4,487,0)
- +324 ;;=PRINCIPLE CARE MANAGEMENT^14^46
- +325 ;;^UTILITY(U,$J,358.4,488,0)
- +326 ;;=PULSE OXIMETRY^13^47
- +327 ;;^UTILITY(U,$J,358.4,489,0)
- +328 ;;=BLOOD PRESSURE READING^2^47
- +329 ;;^UTILITY(U,$J,358.4,490,0)
- +330 ;;=SELF-CARE MANAGEMENT^14^47
- +331 ;;^UTILITY(U,$J,358.4,491,0)
- +332 ;;=INJECTIONS^11^47
- +333 ;;^UTILITY(U,$J,358.4,492,0)
- +334 ;;=INJECTION ADMINISTRATION^10^47
- +335 ;;^UTILITY(U,$J,358.4,493,0)
- +336 ;;=IMMUNIZATIONS^9^47
- +337 ;;^UTILITY(U,$J,358.4,494,0)
- +338 ;;=IMMUNIZATION ADMINISTRATION^8^47
- +339 ;;^UTILITY(U,$J,358.4,495,0)
- +340 ;;=USE OF INHALER^17^47
- +341 ;;^UTILITY(U,$J,358.4,496,0)
- +342 ;;=BLOOD DRAW(S)^1^47
- +343 ;;^UTILITY(U,$J,358.4,497,0)
- +344 ;;=FAMILY CONSULTATION^3^47
- +345 ;;^UTILITY(U,$J,358.4,498,0)
- +346 ;;=WOUND CARE/TUBE CHANGE^18^47
- +347 ;;^UTILITY(U,$J,358.4,499,0)
- +348 ;;=INSERT CATHETER^12^47
- +349 ;;^UTILITY(U,$J,358.4,500,0)
- +350 ;;=SKIN TEST^15^47
- +351 ;;^UTILITY(U,$J,358.4,501,0)
- +352 ;;=HANDLING OF SPECIMEN(S)^4^47
- +353 ;;^UTILITY(U,$J,358.4,502,0)
- +354 ;;=TEAM CONFERENCE^16^47
- +355 ;;^UTILITY(U,$J,358.4,503,0)
- +356 ;;=HOME HEALTH PROCEDURE/SERVICE^5^47
- +357 ;;^UTILITY(U,$J,358.4,504,0)
- +358 ;;=HOME INFUSION PROC/SVC^6^47
- +359 ;;^UTILITY(U,$J,358.4,505,0)
- +360 ;;=HOME VISITS^7^47
- +361 ;;^UTILITY(U,$J,358.4,506,0)
- +362 ;;=PRESSURE ULCER^14^48
- +363 ;;^UTILITY(U,$J,358.4,507,0)
- +364 ;;=SKIN^19^48
- +365 ;;^UTILITY(U,$J,358.4,508,0)
- +366 ;;=SIGNS AND SYMPTOMS^1^48
- +367 ;;^UTILITY(U,$J,358.4,509,0)
- +368 ;;=CARDIO/VASCULAR^2^48
- +369 ;;^UTILITY(U,$J,358.4,510,0)
- +370 ;;=COUNSELING^3^48
- +371 ;;^UTILITY(U,$J,358.4,511,0)
- +372 ;;=ENDOCRINE,METABOLIC,NUTRITION^4^48
- +373 ;;^UTILITY(U,$J,358.4,512,0)
- +374 ;;=ENT^5^48
- +375 ;;^UTILITY(U,$J,358.4,513,0)
- +376 ;;=GASTROINTESTINAL^6^48
- +377 ;;^UTILITY(U,$J,358.4,514,0)
- +378 ;;=GENITOURINARY & RENAL^7^48
- +379 ;;^UTILITY(U,$J,358.4,515,0)
- +380 ;;=HEPATITIS^8^48
- +381 ;;^UTILITY(U,$J,358.4,516,0)
- +382 ;;=IMMUNIZATIONS^9^48
- +383 ;;^UTILITY(U,$J,358.4,517,0)
- +384 ;;=MUSCULOSKELETAL^10^48
- +385 ;;^UTILITY(U,$J,358.4,518,0)
- +386 ;;=NEUROLOGY^11^48
- +387 ;;^UTILITY(U,$J,358.4,519,0)
- +388 ;;=NURSING MISCELLANEOUS^12^48
- +389 ;;^UTILITY(U,$J,358.4,520,0)
- +390 ;;=PREVENTIVE MEDICINE^15^48
- +391 ;;^UTILITY(U,$J,358.4,521,0)
- +392 ;;=PULMONARY/RESPIRATORY^16^48
- +393 ;;^UTILITY(U,$J,358.4,522,0)
- +394 ;;=PSYCHIATRIC^17^48
- +395 ;;^UTILITY(U,$J,358.4,523,0)
- +396 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^48
- +397 ;;^UTILITY(U,$J,358.4,524,0)
- +398 ;;=OSTOMY STATUS^13^48
- +399 ;;^UTILITY(U,$J,358.4,525,0)
- +400 ;;=SCREENING^18^48
- +401 ;;^UTILITY(U,$J,358.4,526,0)
- +402 ;;=ORTHOTIC DEVICES^6^49
- +403 ;;^UTILITY(U,$J,358.4,527,0)
- +404 ;;=THERAPY EVALUATIONS^10^49
- +405 ;;^UTILITY(U,$J,358.4,528,0)
- +406 ;;=HBPC HOME THERAPY SVC (HBPC PT,OT,SLP)^5^49
- +407 ;;^UTILITY(U,$J,358.4,529,0)
- +408 ;;=KT HOME HEALTH SERVICES^5^49
- +409 ;;^UTILITY(U,$J,358.4,530,0)
- +410 ;;=SPEECH/LANG HOME HEALTH SERVICE^8^49
- +411 ;;^UTILITY(U,$J,358.4,531,0)
- +412 ;;=DEVICES/SUPPLIES^3^49
- +413 ;;^UTILITY(U,$J,358.4,532,0)
- +414 ;;=TENS^9^49
- +415 ;;^UTILITY(U,$J,358.4,533,0)
- +416 ;;=ADAPTIVE BEHAVIOR ASSESSMENTS^1^49
- +417 ;;^UTILITY(U,$J,358.4,534,0)
- +418 ;;=ADAPTIVE BEHAVIOR TREATMENT^2^49
- +419 ;;^UTILITY(U,$J,358.4,535,0)
- +420 ;;=PROCEDURES^7^49
- +421 ;;^UTILITY(U,$J,358.4,536,0)
- +422 ;;=FUNCTIONAL OUTCOME ASSESSMENT^4^49
- +423 ;;^UTILITY(U,$J,358.4,537,0)
- +424 ;;=AMPUTATION STATUS^1^50
- +425 ;;^UTILITY(U,$J,358.4,538,0)
- +426 ;;=BRAIN DISORDERS^2^50
- +427 ;;^UTILITY(U,$J,358.4,539,0)
- +428 ;;=CARDIOPULMONARY^4^50
- +429 ;;^UTILITY(U,$J,358.4,540,0)
- +430 ;;=COMPLICATIONS DUE TO^5^50
- +431 ;;^UTILITY(U,$J,358.4,541,0)
- +432 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^50
- +433 ;;^UTILITY(U,$J,358.4,542,0)
- +434 ;;=Z CODES^21^50
- +435 ;;^UTILITY(U,$J,358.4,543,0)
- +436 ;;=BRAIN INJURY - TRAUMATIC^3^50
- +437 ;;^UTILITY(U,$J,358.4,544,0)
- +438 ;;=FEMUR/THIGH/KNEE FRACTURE^7^50
- +439 ;;^UTILITY(U,$J,358.4,545,0)
- +440 ;;=FOOT/TOE/ANKLE FRACTURE^8^50
- +441 ;;^UTILITY(U,$J,358.4,546,0)
- +442 ;;=HAND/FINGER FRACTURE^9^50
- +443 ;;^UTILITY(U,$J,358.4,547,0)
- +444 ;;=HIP/PELVIS FRACTURE^10^50
- +445 ;;^UTILITY(U,$J,358.4,548,0)
- +446 ;;=HUMERUS/SHOULDER FRACTURE^11^50
- +447 ;;^UTILITY(U,$J,358.4,549,0)
- +448 ;;=TIBIA/FIBULA FRACTURE^19^50
- +449 ;;^UTILITY(U,$J,358.4,550,0)
- +450 ;;=SPINE FRACTURE^16^50
- +451 ;;^UTILITY(U,$J,358.4,551,0)
- +452 ;;=WRIST/FOREARM FRACTURE^20^50
- +453 ;;^UTILITY(U,$J,358.4,552,0)
- +454 ;;=OTHER FRACTURE^14^50
- +455 ;;^UTILITY(U,$J,358.4,553,0)
- +456 ;;=PAIN^15^50
- +457 ;;^UTILITY(U,$J,358.4,554,0)
- +458 ;;=SPINAL CONDITIONS^17^50
- +459 ;;^UTILITY(U,$J,358.4,555,0)
- +460 ;;=SYMPTOMS^18^50
- +461 ;;^UTILITY(U,$J,358.4,556,0)
- +462 ;;=FALLS^6^50
- +463 ;;^UTILITY(U,$J,358.4,557,0)
- +464 ;;=NERVES^13^50
- +465 ;;^UTILITY(U,$J,358.4,558,0)
- +466 ;;=OBSERVATION-INIT^10^51
- +467 ;;^UTILITY(U,$J,358.4,559,0)
- +468 ;;=BEDSIDE VISIT-INITIAL CARE^2^51
- +469 ;;^UTILITY(U,$J,358.4,560,0)
- +470 ;;=CONSULTATIONS-INPT^4^51
- +471 ;;^UTILITY(U,$J,358.4,561,0)
- +472 ;;=OBSERVATION-DISCHARGE^12^51
- +473 ;;^UTILITY(U,$J,358.4,562,0)
- +474 ;;=BEDSIDE VISITS-DAILY VISITS^3^51
- +475 ;;^UTILITY(U,$J,358.4,563,0)
- +476 ;;=ADMIT & DISCHARGE SAME DAY^1^51
- +477 ;;^UTILITY(U,$J,358.4,564,0)
- +478 ;;=DISCHARGE DAY CODES^6^51
- +479 ;;^UTILITY(U,$J,358.4,565,0)
- +480 ;;=OBSERVATION-SUBSQ^11^51
- +481 ;;^UTILITY(U,$J,358.4,566,0)
- +482 ;;=POST-OP VISIT^13^51
- +483 ;;^UTILITY(U,$J,358.4,567,0)
- +484 ;;=CRITICAL CARE^5^51
- +485 ;;^UTILITY(U,$J,358.4,568,0)
- +486 ;;=NURS FAC CARE-INIT (SNF,ICF,LTCF)^7^51
- +487 ;;^UTILITY(U,$J,358.4,569,0)
- +488 ;;=NURS FAC CARE-SUBSQ (SNF,ICF,LTCF)^8^51
- +489 ;;^UTILITY(U,$J,358.4,570,0)
- +490 ;;=NURS FAC CARE-D/C SVC (SNF,ICF,LTCF)^9^51
- +491 ;;^UTILITY(U,$J,358.4,571,0)
- +492 ;;=INPT VENT MGMT^4^52
- +493 ;;^UTILITY(U,$J,358.4,572,0)
- +494 ;;=CRITICAL CARE^2^52
- +495 ;;^UTILITY(U,$J,358.4,573,0)
- +496 ;;=TEAM CONFERENCE^8^52
- +497 ;;^UTILITY(U,$J,358.4,574,0)
- +498 ;;=PROLONGED SERVICES^7^52
- +499 ;;^UTILITY(U,$J,358.4,575,0)
- +500 ;;=BEDSIDE PROCEDURES^1^52
- +501 ;;^UTILITY(U,$J,358.4,576,0)
- +502 ;;=MODERATE SEDATION^6^52
- +503 ;;^UTILITY(U,$J,358.4,577,0)
- +504 ;;=MED MANAGEMENT^5^52
- +505 ;;^UTILITY(U,$J,358.4,578,0)
- +506 ;;=IMMUNIZATIONS^3^52
- +507 ;;^UTILITY(U,$J,358.4,579,0)
- +508 ;;=SIGNS/SYMPTOMS^16^53
- +509 ;;^UTILITY(U,$J,358.4,580,0)
- +510 ;;=PAIN^14^53
- +511 ;;^UTILITY(U,$J,358.4,581,0)
- +512 ;;=MASS^10^53
- +513 ;;^UTILITY(U,$J,358.4,582,0)
- +514 ;;=COMPLICATIONS^3^53
- +515 ;;^UTILITY(U,$J,358.4,583,0)
- +516 ;;=CARDIOVASCULAR^2^53
- +517 ;;^UTILITY(U,$J,358.4,584,0)
- +518 ;;=RESPIRATORY^15^53
- +519 ;;^UTILITY(U,$J,358.4,585,0)
- +520 ;;=GASTROENTEROLOGY^5^53
- +521 ;;^UTILITY(U,$J,358.4,586,0)
- +522 ;;=GENITORURINARY^6^53
- +523 ;;^UTILITY(U,$J,358.4,587,0)
- +524 ;;=MUSCULOSKELETAL^12^53
- +525 ;;^UTILITY(U,$J,358.4,588,0)
- +526 ;;=NEUROLOGY^13^53
- +527 ;;^UTILITY(U,$J,358.4,589,0)
- +528 ;;=HEMATOLOGY/ONCOLOGY^7^53
- +529 ;;^UTILITY(U,$J,358.4,590,0)
- +530 ;;=INFECTIOUS DISEASE^9^53
- +531 ;;^UTILITY(U,$J,358.4,591,0)
- +532 ;;=SUBSTANCE ABUSE-ALCOHOL^18^53
- +533 ;;^UTILITY(U,$J,358.4,592,0)
- +534 ;;=SUBSTANCE ABUSE-AMPHETAMINE^19^53
- +535 ;;^UTILITY(U,$J,358.4,593,0)
- +536 ;;=SUBSTANCE ABUSE-CANNABIS^20^53
- +537 ;;^UTILITY(U,$J,358.4,594,0)
- +538 ;;=SUBSTANCE ABUSE-COCAINE^21^53
- +539 ;;^UTILITY(U,$J,358.4,595,0)
- +540 ;;=SUBSTANCE ABUSE-HALLUCINOGEN^22^53
- +541 ;;^UTILITY(U,$J,358.4,596,0)
- +542 ;;=SUBSTANCE ABUSE-INHALANT^23^53
- +543 ;;^UTILITY(U,$J,358.4,597,0)
- +544 ;;=SUBSTANCE ABUSE-OPIOID^24^53
- +545 ;;^UTILITY(U,$J,358.4,598,0)
- +546 ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^25^53
- +547 ;;^UTILITY(U,$J,358.4,599,0)
- +548 ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^26^53
- +549 ;;^UTILITY(U,$J,358.4,600,0)
- +550 ;;=SUBSTANCE ABUSE-TOBACCO^27^53
- +551 ;;^UTILITY(U,$J,358.4,601,0)
- +552 ;;=ENDOCRINE^4^53
- +553 ;;^UTILITY(U,$J,358.4,602,0)
- +554 ;;=ICU^8^53
- +555 ;;^UTILITY(U,$J,358.4,603,0)
- +556 ;;=SUICIDAL IDEATIONS/ATTEMPTS^28^53
- +557 ;;^UTILITY(U,$J,358.4,604,0)
- +558 ;;=MISCELLANEOUS^11^53
- +559 ;;^UTILITY(U,$J,358.4,605,0)
- +560 ;;=GENERAL IM^1^53
- +561 ;;^UTILITY(U,$J,358.4,606,0)
- +562 ;;=SOCIAL DETERMINANTS OF HEALTH^17^53
- +563 ;;^UTILITY(U,$J,358.4,607,0)
- +564 ;;=NEW PATIENT^2^54
- +565 ;;^UTILITY(U,$J,358.4,608,0)
- +566 ;;=ESTABLISHED PATIENT^1^54
- +567 ;;^UTILITY(U,$J,358.4,609,0)
- +568 ;;=CONSULTATIONS^3^54
- +569 ;;^UTILITY(U,$J,358.4,610,0)
- +570 ;;=PREVENTIVE MED-EST PT^4^54
- +571 ;;^UTILITY(U,$J,358.4,611,0)
- +572 ;;=PREVENTIVE MED-NEW PT^5^54
- +573 ;;^UTILITY(U,$J,358.4,612,0)
- +574 ;;=TRANSITIONAL CARE MGNT (TCM)^6^54
- +575 ;;^UTILITY(U,$J,358.4,613,0)
- +576 ;;=IMMUNIZATIONS^6^55
- +577 ;;^UTILITY(U,$J,358.4,614,0)
- +578 ;;=INJECTION^7^55
- +579 ;;^UTILITY(U,$J,358.4,615,0)
- +580 ;;=SKIN TESTS^15^55
- +581 ;;^UTILITY(U,$J,358.4,616,0)
- +582 ;;=NURSING PROCEDURES^9^55
- +583 ;;^UTILITY(U,$J,358.4,617,0)
- +584 ;;=MINOR PROCEDURES^8^55
- +585 ;;^UTILITY(U,$J,358.4,618,0)
- +586 ;;=SPLINTS^16^55
- +587 ;;^UTILITY(U,$J,358.4,619,0)
- +588 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^14^55
- +589 ;;^UTILITY(U,$J,358.4,620,0)
- +590 ;;=REPAIR-SIMPLE FACE,MUCOUS^13^55
- +591 ;;^UTILITY(U,$J,358.4,621,0)
- +592 ;;=IMMUNIZATION ADMIN^5^55
- +593 ;;^UTILITY(U,$J,358.4,622,0)
- +594 ;;=BEHAVIOR CHANGE INTERVENTION^2^55
- +595 ;;^UTILITY(U,$J,358.4,623,0)
- +596 ;;=ADVANCE CARE PLANNING^1^55
- +597 ;;^UTILITY(U,$J,358.4,624,0)
- +598 ;;=PREVENTIVE MED-EST PT^10^55
- +599 ;;^UTILITY(U,$J,358.4,625,0)
- +600 ;;=PREVENTIVE MED-NEW PT^11^55
- +601 ;;^UTILITY(U,$J,358.4,626,0)
- +602 ;;=E-CONSULT REFERRAL^4^55
- +603 ;;^UTILITY(U,$J,358.4,627,0)
- +604 ;;=COVID-19 RELATED^3^55
- +605 ;;^UTILITY(U,$J,358.4,628,0)
- +606 ;;=PROLONGED SERVICES^12^55
- +607 ;;^UTILITY(U,$J,358.4,629,0)
- +608 ;;=PC COMMON DIAGNOSES^1^56
- +609 ;;^UTILITY(U,$J,358.4,630,0)
- +610 ;;=ADMINISTRATIVE TOPICS^15^56
- +611 ;;^UTILITY(U,$J,358.4,631,0)
- +612 ;;=ANGINA^16^56
- +613 ;;^UTILITY(U,$J,358.4,632,0)
- +614 ;;=ATHEROSCLEROSIS^17^56
- +615 ;;^UTILITY(U,$J,358.4,633,0)
- +616 ;;=CARDIOVASCULAR^18^56
- +617 ;;^UTILITY(U,$J,358.4,634,0)
- +618 ;;=DERMATOLOGY^22^56
- +619 ;;^UTILITY(U,$J,358.4,635,0)
- +620 ;;=EAR DISORDERS^24^56
- +621 ;;^UTILITY(U,$J,358.4,636,0)
- +622 ;;=EENT^25^56
- +623 ;;^UTILITY(U,$J,358.4,637,0)
- +624 ;;=ENDOCRINE/METABOLIC^26^56
- +625 ;;^UTILITY(U,$J,358.4,638,0)
- +626 ;;=EYE DISORDERS^27^56
- +627 ;;^UTILITY(U,$J,358.4,639,0)
- +628 ;;=EYE INJURY^28^56
- +629 ;;^UTILITY(U,$J,358.4,640,0)
- +630 ;;=GASTROENTEROLOGY^29^56
- +631 ;;^UTILITY(U,$J,358.4,641,0)
- +632 ;;=GU/RENAL^30^56
- +633 ;;^UTILITY(U,$J,358.4,642,0)
- +634 ;;=HEADACHE^31^56
- +635 ;;^UTILITY(U,$J,358.4,643,0)
- +636 ;;=HEART VALVE DISEASE^32^56
- +637 ;;^UTILITY(U,$J,358.4,644,0)
- +638 ;;=HEMATOLOGY/ONCOLOGY^33^56
- +639 ;;^UTILITY(U,$J,358.4,645,0)
- +640 ;;=HISTORY OF ILLNESS^34^56
- +641 ;;^UTILITY(U,$J,358.4,646,0)
- +642 ;;=INFECTIOUS DISEASE^35^56
- +643 ;;^UTILITY(U,$J,358.4,647,0)
- +644 ;;=LIVER DISEASE^36^56
- +645 ;;^UTILITY(U,$J,358.4,648,0)
- +646 ;;=MENTAL HEALTH^38^56
- +647 ;;^UTILITY(U,$J,358.4,649,0)
- +648 ;;=MOVEMENT DISORDERS^39^56